V M Kosma
Overview
Explore the profile of V M Kosma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
173
Citations
2612
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sironen R, Seppa A, Kosma V, Kuopio T
J Clin Pathol
. 2010 Jul;
63(9):848-50.
PMID: 20671044
No abstract available.
2.
Nowee M, Dorsman J, Piek J, Kosma V, Hamalainen K, Verheijen R, et al.
Histopathology
. 2007 Oct;
51(5):666-73.
PMID: 17927588
Aims: To determine expression of p53, HER-2/neu and p27(Kip1) in serous Fallopian tube carcinoma (FTC) in relation to stage and grade, and to investigate DNA copy number changes of HER-2...
3.
Nowee M, Snijders A, Rockx D, de Wit R, Kosma V, Hamalainen K, et al.
J Pathol
. 2007 Aug;
213(1):46-55.
PMID: 17668415
Primary serous ovarian carcinoma (OVCA) and serous Fallopian tube carcinoma (FTC), both belonging to the BRCA-linked tumour spectrum, share many properties and are treated similarly. However, a detailed molecular comparison...
4.
Happo M, Salonen R, Halinen A, Jalava P, Pennanen A, Kosma V, et al.
Inhal Toxicol
. 2007 Mar;
19(3):227-46.
PMID: 17365027
We investigated the dose and time dependency of inflammatory and cytotoxic responses to size-segregated urban air particulate samples in the mouse lung. Coarse (PM10-2.5), fine (PM2.5-0.2), and ultrafine (PM0.2) particles...
5.
Hirvikoski P, Virtaniemi J, Kumpulainen E, Johansson R, Kosma V
Eur J Cancer
. 2002 Aug;
38(13):1717-23.
PMID: 12175687
This study aimed to examine the clinical and biological differences in 198 patients with either T1-T2 local glottic or supraglottic squamous cell carcinomas. The patients with supraglottic cancer had a...
6.
Virtaniemi J, Hirvikoski P, Kumpulainen E, Johansson R, Kosma V
Anticancer Res
. 2002 Mar;
21(6A):4185-8.
PMID: 11911316
Background: The purpose of this study was to analyse the results of salvage surgery after failure of irradiation to control the primary T1-T2 glottic cancer. Materials And Methods: Ninety-eight patients...
7.
Heikkinen P, Kosma V, Hongisto T, Huuskonen H, Hyysalo P, Komulainen H, et al.
Radiat Res
. 2001 Dec;
156(6):775-85.
PMID: 11741502
The increased use of mobile phones has raised the question of possible health effects of such devices, particularly the risk of cancer. It seems unlikely that the low-level radiofrequency (RF)...
8.
Aaltoma S, Lipponen P, Kosma V
Anticancer Res
. 2001 Nov;
21(4B):3101-6.
PMID: 11712818
Objectives: The expression of inducible nitric oxide synthase (iNOS) was evaluated in prostate cancer and the results were compared with other prognostic factors and patients outcome. Materials And Methods: Clinical...
9.
Virtaniemi J, Hirvikoski P, Kumpulainen E, Johansson R, Kulju T, Hujala K, et al.
Duodecim
. 2001 Sep;
114(13):1339-42.
PMID: 11552261
No abstract available.
10.
Ropponen K, Kellokoski J, Pirinen R, Moisio K, Eskelinen M, Alhava E, et al.
J Clin Pathol
. 2001 Jun;
54(7):533-8.
PMID: 11429425
Aims: To investigate whether the three different AP-2 isoforms are expressed differently in colorectal adenomas and carcinomas. Methods: The study comprised 43 randomly selected patients diagnosed and treated at Kuopio...